Euclidean Capital LLC RAPT Holdings History
Euclidean Capital LLC's RAPT Therapeutics Inc Holding Summary
As of 2025-03-31, Euclidean Capital LLC held 82,237.38 shares of RAPT Therapeutics Inc(RAPT), totaling $802,640.00. This investment constitutes 0.3% of their stock portfolio, and Euclidean Capital LLC now holds 0.5% of the outstanding RAPT Therapeutics Inc(RAPT) stock.
The initial trade took place in 2020Q4. And since then Euclidean Capital LLC has made 2 purchases of RAPT, at an average price of $186.93, for a total of 202,337.38 shares. In addition, there have been 3 sales at an average price of $168.76 for 120,100.00 shares. Based on historical transaction data and RAPT's current price of $7.44, Euclidean Capital LLC's estimated gain on his RAPT holdings is $-16.94 Mil, reflecting a -44.80% gain to date.
Euclidean Capital LLC RAPT ($7.44) Holding Chart
Euclidean Capital LLC RAPT ($7.44) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
